[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"QVITI S.A.\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":45},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100454209","neurostimulation-for-the-treatment-of-post-stroke-aphasia-100454209",false,"NCT05194566","Neurostimulation for the Treatment of Post-Stroke Aphasia","Individuals with aphasia (assessed using the Boston Diagnostic Aphasia Examination) who perform the Naming Task in the range of 10%-60% accuracy will be included in the study. The overall baseline score in the Naming Task will be estimated from the two baseline measurements.\n\nInclusion Criteria:\n\n* diagnosis of aphasia: Broca's or mixed (based on the assessment of a Speech Language Pathologist).\n* presence of a focus of injury in the left hemisphere (within one hemisphere only) as a result of the first ischemic or hemorrhagic stroke (based on CT\u002FMRI examination);\n* chronic stage of the disease - time since the stroke occurred over 6 months.\n* ability to achieve an accuracy in the Naming Task of 10-60%.\n* 18-80 years\n* right-handedness before the stroke.\n* ability to give informed written consent.\n* fluency in English.\n\nExclusion Criteria:\n\n* severe cognitive, auditory or visual impairment that would preclude cognitive and language testing - inability to follow a two-step command.\n* presence of metal implants in the skull.\n* presence of major untreated or unstable psychiatric disease.\n* history of epilepsy or seizures.\n* ongoing medication that increases the risk of epileptic seizures.\n* presence in the body of cardiac stimulator, pacemaker or vagus nerve stimulator (implanted).\n* history of speech, language, hearing, or intellectual disability during childhood.\n* pregnancy (based on declarations)\n\nExclusion criteria during the trial:\n\n* high intolerance to stimulation.\n* occurrence of an epileptic seizure.\n* other previously absent neurological or mental symptoms\n\nWithdrawal criteria:\n\n* high intolerance to stimulation (participants experience severe discomfort during stimulation);\n* occurrence of an epileptic seizure;\n* other previously absent neurological, physical or mental symptoms.","ALL","18 Years","80 Years",{"count":19,"type":20},64,"ESTIMATED","INTERVENTIONAL",[23],"NA","The aim of the trial is to determine whether 75Hz transcranial alternating current stimulation (tACS) synchronized with therapeutic linguistic tasks is an effective form of therapy for post-stroke aphasia.",[26],"Post-stroke Aphasia",[28,29,30,31],"speech therapy","brain stimulation","communication","language","RECRUITING","2026-02-13",{"date":35,"type":36},"2026-02-18","ACTUAL",{"date":38,"type":36},"2023-09-06",{"date":40,"type":20},"2026-12",{"name":42,"class":43},"QVITI S.A.","INDUSTRY",2,""]